c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism*

The c-Myc protein is a site-specific DNA-binding transcription factor that is up-regulated in a number of different cancers. We have previously shown that binding of Myc correlates with increased transcription of the cadpromoter. We have now further investigated the mechanism by which Myc mediates transcriptional activation of the cad gene. Using a chromatin immunoprecipitation assay, we found high levels of RNA polymerase II bound to the cad promoter in quiescent NIH 3T3 cells and in differentiated U937 cells, even though the promoter is inactive. However, chromatin immunoprecipitation with an antibody that recognizes the hyperphosphorylated form of the RNA polymerase II carboxyl-terminal domain (CTD) revealed that phosphorylation of the CTD does correlate with c-Myc binding andcad transcription. We have also found that the c-Myc transactivation domain interacts with cdk9 and cyclin T1, components of the CTD kinase P-TEFb. Furthermore, activator bypass experiments have shown that direct recruitment of cyclin T1 to the cadpromoter can substitute for c-Myc to activate the promoter. In summary, our results suggest that c-Myc activates transcription ofcad by stimulating promoter clearance and elongation, perhaps via recruitment of P-TEFb.

[1]  Michael Q. Zhang,et al.  Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters , 2001, Molecular and Cellular Biology.

[2]  M. Eilers,et al.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. , 2001, Genes & development.

[3]  P. Fernandez,et al.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. , 2001, Genes & development.

[4]  B. Peterlin,et al.  NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II , 2001 .

[5]  Chawnshang Chang,et al.  Androgen Receptor Interacts with the Positive Elongation Factor P-TEFb and Enhances the Efficiency of Transcriptional Elongation* , 2001, The Journal of Biological Chemistry.

[6]  Nikita Popov,et al.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  U. Weidle,et al.  The transcriptional program of a human B cell line in response to Myc. , 2001, Nucleic acids research.

[8]  P. Farnham,et al.  Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation* , 2000, The Journal of Biological Chemistry.

[9]  C. Dang,et al.  Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Bentley,et al.  Dynamic association of capping enzymes with transcribing RNA polymerase II. , 2000, Genes & development.

[11]  E. Cho,et al.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. , 2000, Genes & development.

[12]  K. Yamamoto,et al.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.

[13]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[14]  D. Price.  P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II , 2000, Molecular and Cellular Biology.

[15]  J. Lis,et al.  P-TEFb kinase recruitment and function at heat shock loci. , 2000, Genes & development.

[16]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J F Barrett,et al.  Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Ken Chen,et al.  Gene-target recognition among members of the Myc superfamily and implications for oncogenesis , 2000, Nature Genetics.

[19]  B. Amati,et al.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. , 2000, Nucleic acids research.

[20]  M. Cole,et al.  The Essential Cofactor TRRAP Recruits the Histone Acetyltransferase hGCN5 to c-Myc , 2000, Molecular and Cellular Biology.

[21]  R. Young,et al.  Transcription of eukaryotic protein-coding genes. , 2000, Annual review of genetics.

[22]  B. Peterlin,et al.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. , 2000, Immunity.

[23]  P. Farnham,et al.  Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells , 1999, Molecular and Cellular Biology.

[24]  W. Ansorge,et al.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.

[25]  A. Giordano,et al.  Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo , 1999, Oncogene.

[26]  J. Greenblatt,et al.  Activation of the Murine Dihydrofolate Reductase Promoter by E2F1 , 1999, The Journal of Biological Chemistry.

[27]  C. Vinson,et al.  Cell-Type-Dependent Activity of the Ubiquitous Transcription Factor USF in Cellular Proliferation and Transcriptional Activation , 1999, Molecular and Cellular Biology.

[28]  M. Cole,et al.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. , 1998, Genes & development.

[29]  P. Farnham,et al.  c-Myc target gene specificity is determined by a post-DNAbinding mechanism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Orphanides,et al.  A Human RNA Polymerase II Complex Containing Factors That Modify Chromatin Structure , 1998, Molecular and Cellular Biology.

[31]  S. Pinaud,et al.  Regulation of c-fos expression by RNA polymerase elongation competence. , 1998, Journal of molecular biology.

[32]  P. Grant,et al.  Transcriptional activators direct histone acetyltransferase complexes to nucleosomes , 1998, Nature.

[33]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[34]  J. Lis,et al.  Direct cloning of DNA that interacts in vivo with a specific protein: application to RNA polymerase II and sites of pausing in Drosophila. , 1998, Nucleic acids research.

[35]  M. Garber,et al.  HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. , 1998, Cold Spring Harbor symposia on quantitative biology.

[36]  R. Conaway,et al.  A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Kremmer,et al.  Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity , 1997, Current Biology.

[38]  Hiroyoshi Ariga,et al.  Cross-family interaction between the bHLHZip USF and bZip Fra1 proteins results in down-regulation of AP1 activity , 1997, Oncogene.

[39]  P. Farnham,et al.  Myc versus USF: discrimination at the cad gene is determined by core promoter elements , 1997, Molecular and cellular biology.

[40]  J. Chrivia,et al.  CREB-binding Protein Activates Transcription through Multiple Domains* , 1996, The Journal of Biological Chemistry.

[41]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[42]  A. Rice,et al.  Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8. , 1996, Nucleic acids research.

[43]  M. Dahmus.  Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II* , 1996, The Journal of Biological Chemistry.

[44]  J. Greenblatt,et al.  Three functional classes of transcriptional activation domain , 1996, Molecular and cellular biology.

[45]  M. Sawadogo,et al.  Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains , 1996, Molecular and cellular biology.

[46]  L. Desbarats,et al.  Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. , 1996, Genes & development.

[47]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[48]  P. Farnham,et al.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants , 1995, Molecular and cellular biology.

[49]  R. Eisenman,et al.  Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.

[50]  P. Farnham,et al.  Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. , 1994, The Journal of biological chemistry.

[51]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Farnham,et al.  A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter , 1993, Molecular and cellular biology.

[53]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[54]  M. Groudine,et al.  The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. , 1992, Genes & development.

[55]  P. Farnham,et al.  The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter , 1992, Molecular and cellular biology.

[56]  J. Lis,et al.  RNA polymerase II pauses at the 5' end of the transcriptionally induced Drosophila hsp70 gene , 1991, Molecular and cellular biology.

[57]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[58]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[59]  P. Farnham,et al.  Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site , 1990, Molecular and cellular biology.

[60]  R. Palmiter,et al.  Oncogene-induced liver neoplasia in transgenic mice. , 1989, Oncogene.

[61]  A. W. Harris,et al.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells , 1988, The Journal of experimental medicine.

[62]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[63]  H. Varmus,et al.  Definition of regions in human c-myc that are involved in transformation and nuclear localization , 1987, Molecular and cellular biology.

[64]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.